Immunic Stock Is Trading Lower After Equity Raise Of $45M To Fund Lead Pipeline Candidates
Immunic Inc (NASDAQ:IMUX) has priced an underwritten public offering of 4.5 million shares at $10 per share, representing a discount…
Immunic Announces Pricing Of $45M Public Offering Of 4.5M Shares Of Common Stock
Immunic, Inc. (the "Company") (NASDAQ:IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
22 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares rose 63.2% to $8.03 in pre-market trading after jumping around 8% on Wednesday.
Immunic Stock Jumps As FDA Signs Off On 2 Clinical Trial Applications
The FDA has signed off Immunic Inc’s (NASDAQ:IMUX) investigational new drug application for the Phase 3 ENSURE program of lead asset…
72 Biggest Movers From Yesterday
Gainers
SemiLEDs Corporation (NASDAQ: LEDS) shares surged 85.8% to settle at $10.22 on above-average volume.